-
Je něco špatně v tomto záznamu ?
Postpartum profiling of microRNAs involved in pathogenesis of cardiovascular/cerebrovascular diseases in women exposed to pregnancy-related complications
I. Hromadnikova, K. Kotlabova, L. Dvorakova, L. Krofta,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
Grantová podpora
NV16-27761A
MZ0
CEP - Centrální evidence projektů
- MeSH
- cerebrovaskulární poruchy diagnóza genetika MeSH
- dospělí MeSH
- genetický profil MeSH
- hypertenze indukovaná těhotenstvím diagnóza genetika MeSH
- kardiovaskulární nemoci diagnóza genetika MeSH
- kohortové studie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikro RNA genetika MeSH
- následné studie MeSH
- pilotní projekty MeSH
- poporodní období genetika MeSH
- preeklampsie diagnóza genetika MeSH
- prospektivní studie MeSH
- růstová retardace plodu diagnóza genetika MeSH
- těhotenství MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND AND METHODS: Gestational hypertension (GH), preeclampsia (PE) and fetal growth restriction (FGR) may predispose to later onset of cardiovascular/cerebrovascular diseases. We examined if pregnancy complications induce postpartum alterations in gene expression of cardiovascular/cerebrovascular disease associated microRNAs. 29 microRNAs were tested in peripheral blood of women, compared between groups with a history of GH, PE, FGR and controls, and correlated with the severity of the disease regarding clinical signs, delivery date, and Doppler parameters. RESULTS: GH was associated with the up-regulation of miR-20a-5p, miR-143-3p, miR-146a-5p, miR-181a-5p, miR-199a-5p, miR-221-3p, and miR-499a-5p. The up-regulation of miR-17-5p, miR-20b-5p, miR-29a-3p, and miR-126-3p was a mutual phenomenon of GH and severe PE. GH and early PE were associated with up-regulation of miR-1-3p and miR-17-5p. GH and late PE showed up-regulation of miR-17-5p, miR-20b-5p, and miR-29a-3p. Severe PE induced up-regulation of miR-133a-3p and down-regulation of miR-130b-3p. MiR-133a-3p up-regulation was also observed in early PE. PE and/or FGR with abnormal Doppler parameters demonstrated up-regulation of miR-100-5p, miR-125b-5p, miR-133a-3p, and miR-145-5p. The combination screening was superior over using individual microRNAs for patients with GH, PE regardless of the severity of the disease, severe PE and early PE. A cardiovascular risk at patients with late PE, PE and/or FGR with abnormal Doppler parameters was identified more accurately using the single microRNA only. CONCLUSION: Epigenetic changes characteristic for cardiovascular/cerebrovascular diseases are present in women with a prior exposure to pregnancy complications. Screening of microRNAs may be used to identify patients at a higher risk of later development of cardiovascular/cerebrovascular diseases.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023676
- 003
- CZ-PrNML
- 005
- 20201214130812.0
- 007
- ta
- 008
- 201125s2019 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijcard.2019.05.036 $2 doi
- 035 __
- $a (PubMed)31151766
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Hromadnikova, Ilona $u Department of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Electronic address: Ilona.Hromadnikova@lf3.cuni.cz.
- 245 10
- $a Postpartum profiling of microRNAs involved in pathogenesis of cardiovascular/cerebrovascular diseases in women exposed to pregnancy-related complications / $c I. Hromadnikova, K. Kotlabova, L. Dvorakova, L. Krofta,
- 520 9_
- $a BACKGROUND AND METHODS: Gestational hypertension (GH), preeclampsia (PE) and fetal growth restriction (FGR) may predispose to later onset of cardiovascular/cerebrovascular diseases. We examined if pregnancy complications induce postpartum alterations in gene expression of cardiovascular/cerebrovascular disease associated microRNAs. 29 microRNAs were tested in peripheral blood of women, compared between groups with a history of GH, PE, FGR and controls, and correlated with the severity of the disease regarding clinical signs, delivery date, and Doppler parameters. RESULTS: GH was associated with the up-regulation of miR-20a-5p, miR-143-3p, miR-146a-5p, miR-181a-5p, miR-199a-5p, miR-221-3p, and miR-499a-5p. The up-regulation of miR-17-5p, miR-20b-5p, miR-29a-3p, and miR-126-3p was a mutual phenomenon of GH and severe PE. GH and early PE were associated with up-regulation of miR-1-3p and miR-17-5p. GH and late PE showed up-regulation of miR-17-5p, miR-20b-5p, and miR-29a-3p. Severe PE induced up-regulation of miR-133a-3p and down-regulation of miR-130b-3p. MiR-133a-3p up-regulation was also observed in early PE. PE and/or FGR with abnormal Doppler parameters demonstrated up-regulation of miR-100-5p, miR-125b-5p, miR-133a-3p, and miR-145-5p. The combination screening was superior over using individual microRNAs for patients with GH, PE regardless of the severity of the disease, severe PE and early PE. A cardiovascular risk at patients with late PE, PE and/or FGR with abnormal Doppler parameters was identified more accurately using the single microRNA only. CONCLUSION: Epigenetic changes characteristic for cardiovascular/cerebrovascular diseases are present in women with a prior exposure to pregnancy complications. Screening of microRNAs may be used to identify patients at a higher risk of later development of cardiovascular/cerebrovascular diseases.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a kardiovaskulární nemoci $x diagnóza $x genetika $7 D002318
- 650 _2
- $a cerebrovaskulární poruchy $x diagnóza $x genetika $7 D002561
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a růstová retardace plodu $x diagnóza $x genetika $7 D005317
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a genetický profil $7 D000076610
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypertenze indukovaná těhotenstvím $x diagnóza $x genetika $7 D046110
- 650 _2
- $a mikro RNA $x genetika $7 D035683
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a pilotní projekty $7 D010865
- 650 _2
- $a poporodní období $x genetika $7 D049590
- 650 _2
- $a preeklampsie $x diagnóza $x genetika $7 D011225
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a prospektivní studie $7 D011446
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kotlabova, Katerina $u Department of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Dvorakova, Lenka $u Department of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Krofta, Ladislav $u Institute for the Care of the Mother and Child, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
- 773 0_
- $w MED00002299 $t International journal of cardiology $x 1874-1754 $g Roč. 291, č. - (2019), s. 158-167
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31151766 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214130811 $b ABA008
- 999 __
- $a ok $b bmc $g 1595995 $s 1114352
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 291 $c - $d 158-167 $e 20190521 $i 1874-1754 $m International journal of cardiology $n Int J Cardiol $x MED00002299
- GRA __
- $a NV16-27761A $p MZ0
- LZP __
- $a Pubmed-20201125
